[Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
In recent years, assay levels of natriuretic peptides are used in everyday clinical practice. The most commonly used is the assay the concentration of NT-proBNP in conjunction with the longest half-life (120 minutes) and its stability. According to the guidelines of the European Society of Cardiology determination of NT-proBNP were used in the diagnosis of acute and chronic heart failure, risk stratification in acute coronary syndromes, pulmonary embolism and in assessing the overall risk of cardiovascular patients prior to surgery. In addition, there are works whose authors have demonstrated the usefulness of NT-proBNP determination in valvular, atrial fibrillation, and syncope.
Piotr J
PJ
Stryjewski
Bohdan
B
Nessler
Matusik
M
Paweł
Leszek
L
Badacz
Jacek
J
Nowak
Jadwiga
J
Nessler
D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002309:Cardiology / Q000592:standards; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000378:metabolism; D005060:Europe; D006207:Half-Life; D006333:Heart Failure / Q000175:diagnosis* / Q000378:metabolism*; D006801:Humans; D045265:Natriuretic Peptides / Q000378:metabolism*; D017410:Practice Guidelines as Topic; D011300:Preoperative Care; D011655:Pulmonary Embolism / Q000145:classification / Q000378:metabolism; D012955:Societies, Medical / Q000592:standards
D015415:Biomarkers; D045265:Natriuretic Peptides